The company's historical ROCE trend is uninspiring, and the increase in capital employed indicates that the business isn't investing in high return investments. The stock lacks multi-bagger traits, dampening investor optimism for trend improvement.
The company's low P/E ratio reflects expectations of persistent disappointing earnings performance. With bleak prospects for profitability, the P/E ratio could fall even lower as investors remain wary.
The company's low P/E ratio is due to expected further disappointing earnings. Without improved profitability, this could decrease further. Investors see no significant earnings improvement to justify a higher P/E ratio.
C.Q. Pharmaceutical Holding Stock Forum
No comment yet